Executive Summary

Investment Thesis: Berkshire Hathaway presents a paradox for investors. The company owns a gigantic, liquid capital base, diversified insurance and operating businesses, and generated meaningful net income and free cash flow in the trailing twelve months. At the same time analysts are cautious and headline price metrics show the stock trading well below recent highs, leaving upside tied largely to capital deployment and investment returns rather than organic revenue acceleration. You should view BRK-B as a cash-and-capital-allocation vehicle with operational exposure to insurance and industrials.

Current Price: $479.21 | Key Metric: P/E 15.37 | Stance: NEUTRAL

Company Overview

Berkshire Hathaway Inc ($BRK-B) is a diversified holding company with major operations in insurance, utilities, manufacturing, retail, and a large publicly traded securities portfolio. Management, led historically by Warren Buffett and long-time lieutenants, emphasizes capital allocation across whole-company acquisitions, minority stakes, and opportunistic share repurchases.

Key Products & Competitive Position

Core Business: Insurance underwriting and reinsurance, which produces float that fuels investments and acquisitions.
Key Products: Property and casualty insurance, reinsurance, railroad services through BNSF (indirect), utilities and energy, large operating businesses such as Berkshire Hathaway Energy, manufacturing firms, and a diversified investment portfolio including large holdings in public equities.
Competitive Moat: A diversified underwriting franchise, long-term capital allocation expertise, scale advantages in acquisitions, and a rare, high-liquidity cash position that allows flexibility during market dislocations.

Recent Developments

Berkshire ended the trailing period with substantial liquidity, reported strong net income and free cash flow, and continues to operate a broad set of businesses with stable recurring cash. Analysts have diverged on near-term return potential, with some upgrading price targets while the overall consensus sits on the cautious side. The next event market participants are watching is Q1 2026 earnings, expected after market close on 2026-05-01.

Financial Snapshot

Market Cap$1029.19B

P/E Ratio15.37

52-Week Range$685,150 - $812,855

Dividend Yield0.0%

EPS (TTM)$46,570.24

ROE9.78%

Revenue & Earnings Trends

Berkshire reported trailing twelve month revenue of roughly $371.4B and net income available to common shareholders near $67.0B, producing an operating profit mix dominated by insurance underwriting results and investment gains. Revenue and earnings are heavily influenced by macro cycles and the performance of the public securities portfolio. Profit margin on a trailing basis has been strong, supported by investment income and large operating subsidiaries.

Balance Sheet Highlights

The balance sheet is a core strength. Total cash and equivalents are reported above $370B, while total debt remains modest relative to assets with a debt to equity figure under 20%. Current ratio is 1.36, signaling adequate short-term liquidity. The combination of an enormous cash position and diversified operating cash flow gives management room to deploy capital over time.

Valuation Analysis

Current Valuation Metrics

Forward P/E~21.7vs Industry: ~12-18

PEG RatioN/AGrowth-adjusted

EV/EBITDAN/Avs Historical: N/A

P/S Ratio~2.5vs Peers: 1.0-3.0

Historical Comparison

On a trailing P/E of roughly 15, Berkshire is trading below many growth-oriented financials but not far from historical averages for diversified insurers that combine operating subsidiaries with an investment portfolio. The forward P/E above 20 suggests market expectation of slower near-term earnings or reduced realized investment gains versus past periods.

Fair Value Estimate

A blended approach that weighs the balance sheet, recurring operating cash flow, and normalized investment returns suggests a fair value near the mid-to-high $500s on available analyst targets when accounting for a normalized earnings run rate. That fair value assumes prudent capital deployment and market returns consistent with long-term averages. If capital is deployed conservatively into lower-return assets, the fair value moves lower.

Competitive Landscape

Market Position

Market Share: Not directly applicable across diverse segments | Ranking: One of the largest diversified insurance and holding companies globally

Key Competitors

$AIGLarge insurer with global operations, more exposed to reinsurance volatility.

$ALLSpecialty insurer with a strong commercial book, different capital allocation model.

$BRK-AClass A shares of the same company, trades at roughly 1500x B share level, relevant for class comparison.

Competitive Advantages

Moat 1: Enormous, liquid capital base that supports underwriting and opportunistic purchases.
Moat 2: Decades of proven capital allocation experience and an accumulated track record in acquisitions and public equity investments.
Moat 3: Diversification across insurance, utilities, manufacturing and services, buffering single-industry shocks.

Earnings Track Record

Last 4 Quarters: Mixed (estimated 2 beats / 2 misses)

Recent Earnings History

Q4 2025Revenue $94.23BREPORTED

Q3 2025Solid operating results across insurance and subsidiariesREPORTED

Q2 2025Investment volatility impacted realized gainsREPORTED

Q1 2025Stable underwriting margins, strong cash flowREPORTED

Guidance Trend

Management historically offers limited forward guidance, preferring to discuss capital allocation and long-term positioning in annual letters and shareholder meetings. Market expectations are therefore driven by analyst modeling of investment returns and underwriting performance, which can shift materially with market moves.

Analyst Sentiment

Consensus Rating: Sell

Strong Buy: 0 Buy: 1 Hold: 3 Sell: 3 Strong Sell: 3

Price Targets

Low: $481
Mean: $523 (+9.1% upside)
High: $578

Recent Analyst Actions

UBS maintained a Buy and slightly raised its price target into the high $500s on 2025-11-03, reflecting conviction that capital deployment will generate outsized returns. Other houses remain cautious, pointing to valuation complacency and the need for clearer catalysts.

Technical Outlook

Current Price: $479.21 vs 52-Week High: $539.80 (-11.1% from high)

Trend Analysis

On shorter timeframes $BRK-B has shown relative stability, reflecting low beta and diversified cash flows. The stock has retraced from prior highs, and volume patterns indicate investors are selective on new exposures. Momentum is muted, which is consistent with a low-beta profile and the lack of near-term transformative catalysts.

Key Levels

Resistance: $520, $560
Support: $440, $396

Bull vs Bear Case

Bull Case

Catalyst 1: Management deploys large cash balances into high-return acquisitions, lifting intrinsic value.
Catalyst 2: Strong underwriting cycles improve insurance margins, adding to operating income.
Catalyst 3: Recovery or gains in the public securities portfolio deliver outsized realized gains, supporting EPS and book value growth.

Bull Target: $650 (+35% from current)

Bear Case

Risk 1: Capital is deployed into lower-return or overvalued assets, compressing future returns.
Risk 2: Adverse underwriting cycles, catastrophe losses, or higher reserve development reduce insurance profitability.
Risk 3: Market declines trigger mark-to-market losses in the securities portfolio and limit realized gains.

Bear Target: $420 (-12% from current)

Risks to Consider

Valuation Risk: Even with a low trailing P/E, forward expectations and cash deployment decisions could make the stock expensive if returns disappoint.
Competitive Risk: Insurance markets are cyclical, and competitors can pressure pricing or capital returns, shrinking underwriting margins.
Macro Risk: Interest rate moves and equity market volatility affect investment income and the marked-to-market value of the securities portfolio.
Execution Risk: Large-scale acquisitions require discipline. Poor integration or overpayment would weigh on intrinsic value.

Bottom Line

Investment Verdict: NEUTRAL

Berkshire Hathaway combines a rare combination of scale, liquidity, and diversified operating earnings. Data suggests the company is relatively cheaply priced on trailing earnings and benefits from a fortress balance sheet, but upside is closely tied to management's ability to deploy capital at attractive returns and to the performance of the securities portfolio. Analysts remain split, so clarity on capital deployment would be the clearest catalyst for a re-rating.

Action Items for Investors

Long-term investors: Monitor quarterly commentary on capital deployment and track changes in investment income and float. Consider allocation decisions in the context of your long-term portfolio mix rather than event-driven moves.
Short-term traders: Watch earnings on 2026-05-01 and use technical levels for entry and exit, given muted momentum and clear support/resistance bands.
Risk management: Given concentration in insurance and public equities, size positions to reflect potential realized volatility and the company’s sensitivity to macro shifts.

What to Watch This Week

Any pre-earnings analyst notes or revisions ahead of the 2026-05-01 report.
News on material M&A activity or announced buyback programs from management.
Macro cues that affect insurance loss trends and public market returns.

BRK-B: Berkshire's Cash Strength vs Analyst Skepticism